US2011052533A1PendingUtilityA1

Compositions and Methods for Cartilage Repair

Assignee: REGENERATIVE SCIENCES LLCPriority: Mar 14, 2008Filed: Mar 13, 2009Published: Mar 3, 2011
Est. expiryMar 14, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61K 31/19A61K 45/06A61K 35/19A61K 38/1825A61P 19/04A61K 35/16A61K 38/1875A61K 31/375A61K 31/573A61K 38/2006A61K 38/1841A61P 19/02A61L 2300/222A61K 35/28A61K 31/7088A61K 38/363A61K 31/56
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Autologous compositions and methods are provided for cartilage repair in patients in need thereof. Some aspects include combinations of platelet-based materials with chondrogenesis inducing agents in the presence or absence of cell-based therapies.

Claims

exact text as granted — not AI-modified
1 . A composition for facilitating cartilage repair in a patient in need thereof comprising a therapeutically effective amount of an autologous platelet lysate and one or more chondrogenesis inducing agents. 
     
     
         2 . The composition of  claim 1  wherein the platelet lysate is from about 5% to about 40% platelet lysate solution. 
     
     
         3 . The composition of  claim 1  wherein the chondrogenesis inducing agent is one or more growth factors, one or more cytokines, one or more hormones, or one or more essential nutrients. 
     
     
         4 . The composition of  claim 3  wherein the chondrogenesis inducing agent is a hormone and wherein the hormone is corticosteroid. 
     
     
         5 . The composition of  claim 3  wherein the chondrogenesis inducing agent is a growth factor and wherein the growth factor is transforming growth factor β, fibroblast growth factor or a bone morphogenetic protein. 
     
     
         6 . The composition of  claim 3  wherein the chondrogenesis inducing agent is a cytokine and wherein the cytokine is IL-1. 
     
     
         7 . The composition of  claim 3  wherein the chondrogenesis inducing agent is an essential nutrient and wherein the essential nutrient is ascorbic acid, collagen, amino acids, peptides, sodium pyruvate, glucose, glutamine, ribonucleosides, carbohydrates, essential oils or deoxyribonucleosides. 
     
     
         8 . The composition of  claim 1  further comprising platelet rich plasma, platelet rich fibrin, whole cell platelets or a mixture thereof. 
     
     
         9 . The composition of  claim 1  further comprising a gel, hydrogel, foam, or other carrier material. 
     
     
         10 . A method for facilitating cartilage repair in a patient in need thereof comprising:
 obtaining platelets from the patient;   preparing a 5% to 40% platelet lysate solution from the platelets;   obtaining one or more chondrogenesis inducing agents; and   administering the 5% to 40% platelet lysate solution and chondrogenesis inducing agent to a site in the patient in need of cartilage repair;   wherein the combined administration of the 5 to 40% platelet lysate solution and chondrogenesis inducing agent facilitates cartilage repair at the site in the patient in need of repair.   
     
     
         11 . The method of  claim 10  wherein the chondrogenesis inducing agent is one or more growth factors, one or more cytokines, one or more hormones, or one or more essential nutrients. 
     
     
         12 . The method of  claim 10  further comprising administering a platelet rich plasma, platelet rich fibrin, whole cell platelet or a mixtures thereof to the patient in need thereof wherein the administration is at the site in the patient in need of repair.

Join the waitlist — get patent alerts

Track US2011052533A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.